HIGH

Glenmark Pharmaceuticals Recalls Azelaic Acid Gel Over Texture Issues

Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.

Hazard Information

CGMP Deviations: Market complaints received for gritty texture (grainy)

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Product Details

The recalled product is Azelaic Acid Gel, 15%, in 50-gram tubes. It is manufactured by Glenmark Pharmaceuticals Limited in Goa, India, for Glenmark Pharmaceuticals Inc. in Mahwah, New Jersey. The affected batch number is 19252524, with an expiration date of May 2027.

The Hazard

The recall is due to CGMP deviations linked to a gritty texture reported by users. This issue does not pose a direct health hazard but may affect the product's effectiveness and user experience.

Reported Incidents

There are no reported injuries or adverse health effects associated with this recall. Complaints focus solely on the product's texture.

What to Do

Consumers should stop using Azelaic Acid Gel immediately. Contact Glenmark Pharmaceuticals Inc. or your healthcare provider for further guidance and possible return options.

Contact Information

For more information, call Glenmark Pharmaceuticals Inc. at their customer service number or visit their website. The recall information is also available on the FDA's website.

Key Facts

  • Recall date: September 17, 2025
  • Quantity recalled: 13,824 tubes
  • Batch number: 19252524
  • Expiration date: May 2027
Advertisement

Safety Assessment

Risk LevelHIGH
Severity Score
4/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Batch # 19252524
Exp Date: May 2027
UPC Codes
68462-626
68462-626-52
Affected States
ALL
Report Date
October 1, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE
Advertisement

Related Recalls

HIGH

Skin MD Body Acne Cleanser Recalled Due to Benzene Contamination

Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.

Skin MD
Chemical Contamination:
Read more